In this context, this study adds to previous evidence supporting the association between TAPSE/sPAP and outcome in PAH [16], albeit suggesting that TAPSE/TRV may be a more specific marker than the former. Here, PDZK1IP1 is linked to pulmonary arterial hypertension.